FDA
approval
· 2017-05-23
FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
Summary
The FDA approved a supplemental application for ZUBSOLV (buprenorphine hydrochloride and naloxone hydrochloride) submitted by Orexo US, Inc. The approval update…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZUBSOLV (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE)